Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miriam Johnson

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
BMJ Open|November 5, 2025
Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised, placebo-controlled trialMarek Jan Atter, Peter Hall, Rachael A Evans, et al.
BMJ Open Respiratory Research|March 22, 2025
Complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): a feasibility, wait-list design randomised controlled trialMichael George Crooks, Caroline Wright, Simon Hart, et al.
BMJ Open|December 9, 2017
Insights from Australians with respiratory disease living in the community with experience of self-managing through an emergency department 'near miss' for breathlessness: a strengths-based qualitative studyTim Luckett, Jane Phillips, Miriam Johnson, et al.
Trials|April 15, 2014
A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods studyJoanna D Smith, Jessica Baillie, Trevor Baglin, et al.
Health Technology Assessment (Winchester, England)|October 23, 2015
A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)Simon I Noble, Annmarie Nelson, David Fitzmaurice, et al.
American Journal of Epidemiology|April 15, 2020
A Dyadic Growth Modeling Approach for Examining Associations Between Weight Gain and Lung Function DeclineTalea Cornelius, Joseph E Schwartz, Pallavi Balte, et al.
BMJ Open|July 19, 2017
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocolDavid Currow, Gareth John Watts, Miriam Johnson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 18, 2026
Non-Pharmacological Breathlessness Action Plans for People with COPD and Their Support People: A Scoping Review and Survey of Current PracticeTim Luckett, Mary M Roberts, Muneeba Tariq Chaudhry, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
BMJ Open|November 5, 2025
Morphine for chronic breathlessness (MABEL) in the UK: a health economic evaluation of a multisite, parallel-group, dose titration, double-blind, randomised, placebo-controlled trialMarek Jan Atter, Peter Hall, Rachael A Evans, et al.
BMJ Open Respiratory Research|March 22, 2025
Complex breathlessness intervention in idiopathic pulmonary fibrosis (BREEZE-IPF): a feasibility, wait-list design randomised controlled trialMichael George Crooks, Caroline Wright, Simon Hart, et al.
BMJ Open|December 9, 2017
Insights from Australians with respiratory disease living in the community with experience of self-managing through an emergency department 'near miss' for breathlessness: a strengths-based qualitative studyTim Luckett, Jane Phillips, Miriam Johnson, et al.
Trials|April 15, 2014
A feasibility study to inform the design of a randomized controlled trial to identify the most clinically and cost effective anticoagulation length with low molecular weight heparin in the treatment of cancer associated thrombosis (ALICAT): study protocol for a mixed-methods studyJoanna D Smith, Jessica Baillie, Trevor Baglin, et al.
Health Technology Assessment (Winchester, England)|October 23, 2015
A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)Simon I Noble, Annmarie Nelson, David Fitzmaurice, et al.
American Journal of Epidemiology|April 15, 2020
A Dyadic Growth Modeling Approach for Examining Associations Between Weight Gain and Lung Function DeclineTalea Cornelius, Joseph E Schwartz, Pallavi Balte, et al.
BMJ Open|July 19, 2017
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocolDavid Currow, Gareth John Watts, Miriam Johnson, et al.
International Journal of Chronic Obstructive Pulmonary Disease|March 18, 2026
Non-Pharmacological Breathlessness Action Plans for People with COPD and Their Support People: A Scoping Review and Survey of Current PracticeTim Luckett, Mary M Roberts, Muneeba Tariq Chaudhry, et al.
Pageof 8